Trans-Arterial Embolization of Renal Cell Carcinoma prior to Percutaneous Ablation: Technical Aspects, Institutional Experience, and Brief Review of the Literature
This report describes the technical aspects of trans-arterial embolization (TAE) of renal cell carcinoma prior to percutaneous ablation. All patients (n = 11) had a single renal mass (mean tumor diameter = 50.2 mm; range: 28-84 mm). Selective TAE was performed via the common femoral artery. Embolic...
Gespeichert in:
| Veröffentlicht in: | Current urology 2018-10, Vol.12 (1), p.43-49 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 49 |
|---|---|
| container_issue | 1 |
| container_start_page | 43 |
| container_title | Current urology |
| container_volume | 12 |
| creator | Gunn, Andrew J. Mullenbach, Benjamin J. Poundstone, May M. Gordetsky, Jennifer B. Underwood, Edgar S. Rais-Bahrami, Soroush |
| description | This report describes the technical aspects of trans-arterial embolization (TAE) of renal cell carcinoma prior to percutaneous ablation. All patients (n = 11) had a single renal mass (mean tumor diameter = 50.2 mm; range: 28-84 mm). Selective TAE was performed via the common femoral artery. Embolic materials included: particles alone (n = 4), coils alone (n = 1), particles + ethiodized oil (n = 2), particles + coils (n = 1), ethiodized oil + ethanol (n = 2), and particles + ethanol (n = 1). All embolizations were technically successful and no complications have been reported. After embolization, 10 patients underwent cryoablation while 1 patient underwent microwave ablation. Ablations were technically successful in 10 of the 11 patients. Only 3 minor complications were identified but none required treatment. No adverse effect on the patient's glomerular filtration rate was seen from the additional procedure (p = 0.84). TAE of renal cell carcinoma prior to percutaneous ablation is safe and technically-feasible. |
| doi_str_mv | 10.1159/000447230 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1159_000447230</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2127203345</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4050-3f85838e81c0683d593d1c574f67a268a21c4b69220e30c2850a063f2957c09d3</originalsourceid><addsrcrecordid>eNptkU1v1DAQhiMEoqVw4I6QJS4gNTC2EyfhgLSsClRaCVRtz5bXmXQNWTu1nfLxd_ijOKREIHHx1zzvvOOZLHtM4SWlZfMKAIqiYhzuZMdUCJpXoqzuLueiOcoehPAZQBSM8_vZEQdeFayG4-zn1isb8pWP6I3qydlh53rzQ0XjLHEduUCbXtfYp0V5baw7KDJ44zyJjnxCr8eoLLoxkNWu_y17Tbao99boJFyFAXUMp-TchmjiOMUnl29DskOr8ZQo25K36TJ53Rj8OrnGPZKNSSWpOHp8mN3rVB_w0e1-kl2-O9uuP-Sbj-_P16tNrgsoIeddXda8xppqEDVvy4a3VJdV0YlKMVErRnWxEw1jgBw0q0tQIHjHmrLS0LT8JHsz5x3G3QFbjTZ61cv024Py36VTRv4bsWYvr9yNFLSpqxpSgue3Cby7HjFEeTBBp97NHZKMsooB50WZ0Bczqr0LwWO32FCQ01DlMtTEPv27roX8M8UEPJmBL8pfoV-ARf_sv-H15cVMyKHt-C-PgLNS</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2127203345</pqid></control><display><type>article</type><title>Trans-Arterial Embolization of Renal Cell Carcinoma prior to Percutaneous Ablation: Technical Aspects, Institutional Experience, and Brief Review of the Literature</title><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Karger Open Access</source><creator>Gunn, Andrew J. ; Mullenbach, Benjamin J. ; Poundstone, May M. ; Gordetsky, Jennifer B. ; Underwood, Edgar S. ; Rais-Bahrami, Soroush</creator><creatorcontrib>Gunn, Andrew J. ; Mullenbach, Benjamin J. ; Poundstone, May M. ; Gordetsky, Jennifer B. ; Underwood, Edgar S. ; Rais-Bahrami, Soroush</creatorcontrib><description>This report describes the technical aspects of trans-arterial embolization (TAE) of renal cell carcinoma prior to percutaneous ablation. All patients (n = 11) had a single renal mass (mean tumor diameter = 50.2 mm; range: 28-84 mm). Selective TAE was performed via the common femoral artery. Embolic materials included: particles alone (n = 4), coils alone (n = 1), particles + ethiodized oil (n = 2), particles + coils (n = 1), ethiodized oil + ethanol (n = 2), and particles + ethanol (n = 1). All embolizations were technically successful and no complications have been reported. After embolization, 10 patients underwent cryoablation while 1 patient underwent microwave ablation. Ablations were technically successful in 10 of the 11 patients. Only 3 minor complications were identified but none required treatment. No adverse effect on the patient's glomerular filtration rate was seen from the additional procedure (p = 0.84). TAE of renal cell carcinoma prior to percutaneous ablation is safe and technically-feasible.</description><identifier>ISSN: 1661-7649</identifier><identifier>EISSN: 1661-7657</identifier><identifier>DOI: 10.1159/000447230</identifier><identifier>PMID: 30374280</identifier><language>eng</language><publisher>Basel, Switzerland: S. Karger AG</publisher><subject>Surgical Technique</subject><ispartof>Current urology, 2018-10, Vol.12 (1), p.43-49</ispartof><rights>2018 The Author(s) Published by S. Karger AG, Basel</rights><rights>Copyright © 2018 by S. Karger AG, Basel 2018</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4050-3f85838e81c0683d593d1c574f67a268a21c4b69220e30c2850a063f2957c09d3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6198780/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6198780/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,860,881,27612,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30374280$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gunn, Andrew J.</creatorcontrib><creatorcontrib>Mullenbach, Benjamin J.</creatorcontrib><creatorcontrib>Poundstone, May M.</creatorcontrib><creatorcontrib>Gordetsky, Jennifer B.</creatorcontrib><creatorcontrib>Underwood, Edgar S.</creatorcontrib><creatorcontrib>Rais-Bahrami, Soroush</creatorcontrib><title>Trans-Arterial Embolization of Renal Cell Carcinoma prior to Percutaneous Ablation: Technical Aspects, Institutional Experience, and Brief Review of the Literature</title><title>Current urology</title><addtitle>Curr Urol</addtitle><description>This report describes the technical aspects of trans-arterial embolization (TAE) of renal cell carcinoma prior to percutaneous ablation. All patients (n = 11) had a single renal mass (mean tumor diameter = 50.2 mm; range: 28-84 mm). Selective TAE was performed via the common femoral artery. Embolic materials included: particles alone (n = 4), coils alone (n = 1), particles + ethiodized oil (n = 2), particles + coils (n = 1), ethiodized oil + ethanol (n = 2), and particles + ethanol (n = 1). All embolizations were technically successful and no complications have been reported. After embolization, 10 patients underwent cryoablation while 1 patient underwent microwave ablation. Ablations were technically successful in 10 of the 11 patients. Only 3 minor complications were identified but none required treatment. No adverse effect on the patient's glomerular filtration rate was seen from the additional procedure (p = 0.84). TAE of renal cell carcinoma prior to percutaneous ablation is safe and technically-feasible.</description><subject>Surgical Technique</subject><issn>1661-7649</issn><issn>1661-7657</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>M--</sourceid><recordid>eNptkU1v1DAQhiMEoqVw4I6QJS4gNTC2EyfhgLSsClRaCVRtz5bXmXQNWTu1nfLxd_ijOKREIHHx1zzvvOOZLHtM4SWlZfMKAIqiYhzuZMdUCJpXoqzuLueiOcoehPAZQBSM8_vZEQdeFayG4-zn1isb8pWP6I3qydlh53rzQ0XjLHEduUCbXtfYp0V5baw7KDJ44zyJjnxCr8eoLLoxkNWu_y17Tbao99boJFyFAXUMp-TchmjiOMUnl29DskOr8ZQo25K36TJ53Rj8OrnGPZKNSSWpOHp8mN3rVB_w0e1-kl2-O9uuP-Sbj-_P16tNrgsoIeddXda8xppqEDVvy4a3VJdV0YlKMVErRnWxEw1jgBw0q0tQIHjHmrLS0LT8JHsz5x3G3QFbjTZ61cv024Py36VTRv4bsWYvr9yNFLSpqxpSgue3Cby7HjFEeTBBp97NHZKMsooB50WZ0Bczqr0LwWO32FCQ01DlMtTEPv27roX8M8UEPJmBL8pfoV-ARf_sv-H15cVMyKHt-C-PgLNS</recordid><startdate>20181001</startdate><enddate>20181001</enddate><creator>Gunn, Andrew J.</creator><creator>Mullenbach, Benjamin J.</creator><creator>Poundstone, May M.</creator><creator>Gordetsky, Jennifer B.</creator><creator>Underwood, Edgar S.</creator><creator>Rais-Bahrami, Soroush</creator><general>S. Karger AG</general><scope>M--</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20181001</creationdate><title>Trans-Arterial Embolization of Renal Cell Carcinoma prior to Percutaneous Ablation: Technical Aspects, Institutional Experience, and Brief Review of the Literature</title><author>Gunn, Andrew J. ; Mullenbach, Benjamin J. ; Poundstone, May M. ; Gordetsky, Jennifer B. ; Underwood, Edgar S. ; Rais-Bahrami, Soroush</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4050-3f85838e81c0683d593d1c574f67a268a21c4b69220e30c2850a063f2957c09d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Surgical Technique</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gunn, Andrew J.</creatorcontrib><creatorcontrib>Mullenbach, Benjamin J.</creatorcontrib><creatorcontrib>Poundstone, May M.</creatorcontrib><creatorcontrib>Gordetsky, Jennifer B.</creatorcontrib><creatorcontrib>Underwood, Edgar S.</creatorcontrib><creatorcontrib>Rais-Bahrami, Soroush</creatorcontrib><collection>Karger Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Current urology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gunn, Andrew J.</au><au>Mullenbach, Benjamin J.</au><au>Poundstone, May M.</au><au>Gordetsky, Jennifer B.</au><au>Underwood, Edgar S.</au><au>Rais-Bahrami, Soroush</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Trans-Arterial Embolization of Renal Cell Carcinoma prior to Percutaneous Ablation: Technical Aspects, Institutional Experience, and Brief Review of the Literature</atitle><jtitle>Current urology</jtitle><addtitle>Curr Urol</addtitle><date>2018-10-01</date><risdate>2018</risdate><volume>12</volume><issue>1</issue><spage>43</spage><epage>49</epage><pages>43-49</pages><issn>1661-7649</issn><eissn>1661-7657</eissn><abstract>This report describes the technical aspects of trans-arterial embolization (TAE) of renal cell carcinoma prior to percutaneous ablation. All patients (n = 11) had a single renal mass (mean tumor diameter = 50.2 mm; range: 28-84 mm). Selective TAE was performed via the common femoral artery. Embolic materials included: particles alone (n = 4), coils alone (n = 1), particles + ethiodized oil (n = 2), particles + coils (n = 1), ethiodized oil + ethanol (n = 2), and particles + ethanol (n = 1). All embolizations were technically successful and no complications have been reported. After embolization, 10 patients underwent cryoablation while 1 patient underwent microwave ablation. Ablations were technically successful in 10 of the 11 patients. Only 3 minor complications were identified but none required treatment. No adverse effect on the patient's glomerular filtration rate was seen from the additional procedure (p = 0.84). TAE of renal cell carcinoma prior to percutaneous ablation is safe and technically-feasible.</abstract><cop>Basel, Switzerland</cop><pub>S. Karger AG</pub><pmid>30374280</pmid><doi>10.1159/000447230</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1661-7649 |
| ispartof | Current urology, 2018-10, Vol.12 (1), p.43-49 |
| issn | 1661-7649 1661-7657 |
| language | eng |
| recordid | cdi_crossref_primary_10_1159_000447230 |
| source | DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Karger Open Access |
| subjects | Surgical Technique |
| title | Trans-Arterial Embolization of Renal Cell Carcinoma prior to Percutaneous Ablation: Technical Aspects, Institutional Experience, and Brief Review of the Literature |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T02%3A57%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Trans-Arterial%20Embolization%20of%20Renal%20Cell%20Carcinoma%20prior%20to%20Percutaneous%20Ablation:%20Technical%20Aspects,%20Institutional%20Experience,%20and%20Brief%20Review%20of%20the%20Literature&rft.jtitle=Current%20urology&rft.au=Gunn,%20Andrew%20J.&rft.date=2018-10-01&rft.volume=12&rft.issue=1&rft.spage=43&rft.epage=49&rft.pages=43-49&rft.issn=1661-7649&rft.eissn=1661-7657&rft_id=info:doi/10.1159/000447230&rft_dat=%3Cproquest_cross%3E2127203345%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2127203345&rft_id=info:pmid/30374280&rfr_iscdi=true |